Rituximab, cyclophosphamide, bortezomib and prednisone (R-CBorP): Final results of a phase I trial evaluating two dosing schedules and the safety of overlapping pegfilgrastim in patients with relapsed/refractory indolent and mantle cell lymphomas Meeting Abstract


Authors: Gerecitano, J.; Portlock, C. S.; Hamlin, P. A.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; Iassonos, A.; Zhang, Z.; Horanlli, E.; Rojas, C. N.; Zelenetz, A. D.; O'Connor, O. A.
Abstract Title: Rituximab, cyclophosphamide, bortezomib and prednisone (R-CBorP): Final results of a phase I trial evaluating two dosing schedules and the safety of overlapping pegfilgrastim in patients with relapsed/refractory indolent and mantle cell lymphomas
Meeting Title: 51st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 114
Issue: 22
Meeting Dates: 2009 Dec 5-8
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2009-11-20
Start Page: 1428
Language: English
ACCESSION: WOS:000272725804372
PROVIDER: wos
PUBMED: 22276299
Notes: Meeting Abstract: 3708 -- Source: Wos
MSK Authors
  1. Zhigang Zhang
    249 Zhang
  2. Carol Portlock
    186 Portlock
  3. Craig Moskowitz
    379 Moskowitz
  4. Ariela Noy
    215 Noy
  5. Alexia Elia Iasonos
    188 Iasonos
  6. Andrew D Zelenetz
    579 Zelenetz
  7. Paul Hamlin
    183 Hamlin
  8. David J Straus
    224 Straus